Company: LRHC
Filing Date: 2025-08-18
Form Type: 10-Q
Source: 0001213900-25-078012
Chunk: 49

Company: La Rosa Holdings Corp.
Filing Date: 2025-08-18
Form: 10-Q
Item: Item 1
Chunk 49
---
 the Company recorded $70,953 and $5,514, respectively, of share-based compensation expense related
to the RSUs. As of June 30, 2025, unrecognized compensation expense related to the awards was $268,617, to be expensed over the next 1.6 years. The Company did not realize any
tax benefits associated with share-based compensation for the three-month periods ended June 30, 2025 and 2024, as the Company recorded
a valuation allowance on all deferred tax assets.

24

La Rosa Holdings Corp. and Subsidiaries
Notes to the Unaudited Condensed Consolidated Financial Statements

Note 9 — Earnings Per Share

Basic income (loss) per share of common stock
attributable to common stockholders is computed by dividing net income (loss) attributable to common stockholders by the weighted average
number of shares of common stock outstanding during the period. Diluted income (loss) per share of common stock attributable to common
stockholders is computed by giving effect to all potential shares of common stock, including those related to the Company’s outstanding
warrants, options and RSUs, to the extent dilutive. For certain periods presented, these potential shares were excluded from the calculation
of diluted loss per share because their inclusion would be anti-dilutive. As a result, diluted loss per common share is the same as basic
loss per common share for certain periods presented.

For the three-month period ended June 30, 2025,
as measured in common stock there were 3,660,906 warrants outstanding, 794,361 of convertible Series B Convertible Preferred Stock,
30 outstanding Stock options and 92 unvested restricted stock awards included in the calculation of diluted weighted average
shares outstanding, as such securities were dilutive, resulting in 4,455,389 potential common shares included in the calculation
of diluted EPS. Diluted EPS includes the dilutive effect of securities when the average market price exceeds the exercise price of
the securities, if any, and is calculated using the treasury stock method.

The following tables set forth common stock equivalents
that have been excluded from the computation of dilutive weighted average shares outstanding as their inclusion would have been antidilutive:

    Six Months Ended 

    June 30, 

    2025  
    2024 
  
    Warrants 
     3,705,093  
     604,723